Primary stroke prevention

 

Safe automatic 1-lead ECG screening for atrial fibrillation 

Svennberg E., Stridh M., Engdahl J., Al-Khalili F., Friberg L., Frykman V. & Rosenqvist M.

Europace 2016, Oct 6

Link to poster

Link to study

In this the Zenicor-system algorithm for interpretation support was validated against manual ECG interpretation by cardiologist on 30 seconds ECG strips from lead I. A total of 80,149 ECGs from 3,209 patients from the STROKESTOP I study were analyzed. AF was diagnosed in 84 patients of which the algorithm detected all 84 (100%).


Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study (Main study)

Svennberg, E., Engdahl, J., Al-Khalili, F., Friberg, L., Frykman, V. & Rosenqvist, M.

Circulation. 2015. Jun 23;131(25):2176-84

Link to study

In a globally unique study at Karolinska Institutet, 13.000 people were offered screening for atrial fibrillation with Zenicor-EKG. Five percent of the participants were identified as new candidates for treatment with oral anticoagulants. Health economical calculations based on the results from the study, show that systematic mass screening with Zenicor-ECG for atrial fibrillation is cost-effective.


Stepwise Screening of Atrial Fibrillation in a 75-Year Old Population: Implications for Stroke Prevention (STROKESTOP pilot)

Engdahl J., Andersson L., Mirskaya M., Rosenqvist M.

Circulation (2013;127:930-937)

Link to poster

Link to study

In a pilot for the major STROKESTOP study, around 1.300 75-year-olds in Halland were offered screening for atrial fibrillation. Through a two-week investigation with Zenicor-EKG, 7.2% newly detected atrial fibrillations were diagnosed in the screened population, and the number of people treated with anticoagulants was doubled.


Knowledge resource: Health economics evaluation of primary preventive atrial fibrillation screening with thumb ECG

Tandvårds- och läkemedelsförmånsverket (The Dental and Pharmaceutical Benefits Agency) (2014)

Link to summary

Link to study (Only available in Swedish)

As part of a Government commission to evaluate medical technology, based on figures from the StrokeStop study, TLV (The Dental and Pharmaceutical Benefits Agency) has carried out a health economics assessment of primary preventive fibrillation screening. The report shows that such screening using a thumb ECG is cost-effective.


Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording

Aronsson, M., Svennberg, E., Rosenqvist, M., Endahl, J., Al-Khalili, F., Friberg, L., Frykman-Kull, V. & Levin, L-Å.

Europace. 2015. Apr 13. 1023-1029

Link to study

In a globally unique study at Karolinska Institutet, 13.000 people were offered screening for atrial fibrillation with Zenicor-ECG. Five percent of the participants were identified as new candidates for treatment with oral anticoagulants. According to this Health economical study, based on the results from the STROKESTOP study, systematic mass screening for atrial fibrillation with Zenicor-ECG is cost-effective.


Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP Clinical Trial Design)

Friberg L., Engdahl, J., Frykman, V., Svennberg, E., Levin, L-Å. & Rosenqvist, M.

Clinical Trial Design: Europace (2013;15:135-140)

Link to study

In a globally unique study at Karolinska Institutet, 13.000 people were offered screening for atrial fibrillation with Zenicor-EKG.


Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study.

Engdahl J, Holmén A, Svennberg E, Friberg L, Frykman-Kull V, Al-Khalili F, Rosenqvist M & Strömberg U.

Int J Cardiol. 2016 Jul 29;222:430-435. [Epub ahead of print]

Länk till studie

In an analysis of the persons choosing not to participate in the systematic screening study; STROKESTOP I, the conclusion was drawn that participation was influenced by socioeconomic and geographic conditions. This will provide an important input on how screening for AF should be organized to gain as many as possible. Geographic variation was especially noted in Stockholm that only had one screening centre.


Uptake of atrial fibrillation screening aiming at stroke prevention: geo-mapping of target population and non-participation

Engdahl J., Holmén A., Rosenqvist M. & Strömberg U.

BMC Public Health (2013, 13:715)

Link to study

In an analysis of people who chose not to participate in the StrokeStop pilot screening, the conclusion could be drawn that non-participants mainly came from areas with a higher number of risk factors, a high proportion of immigrants and an older population on average. This provides key data on how a larger screening initiative should be organised in order to benefit as many people as possible.


Screening for atrial fibrillation with baseline and intermittent ECG recording in an out-of-hospital population (FLIP)

Hendrikx T., Hörnsten R., Rosenqvist M., Sandström H.

BMC Cardiovascular Disorders (2013, 13:41)

Link to poster

Link to study

In the FLIP project (Flimmer i Primärvården – atrial fibrillation in primary care) carried out in Västerbotten County, 898 patients with at least one risk factor for stroke (CHADS2 >1) were invited to take part in a four-week investigation with Zenicor-EKG. They took an ECG reading twice a day for 28 days. A total of 4 percent of patients were diagnosed with a previously undetected atrial fibrillation and could be administered oral anticoagulant medication for stroke prevention treatment.